echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > JAHA: Plate plate rest therapy in patients with acute coronary artery syndrome who received coronary artery bridge

    JAHA: Plate plate rest therapy in patients with acute coronary artery syndrome who received coronary artery bridge

    • Last Update: 2021-02-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    For patients with acute coronary syndrome who require coronary artery bridge surgery, the best antiplate plate plate strategy is not yet clear.
    but more effective antiplatelete therapy can easily lead to peri-surgical bleeding.
    The concept of plate platetation is a long-standing concept, recently published in JAHA, an authoritative journal in the field of cardiovascular disease, a research article, the study assumes that the residual plate plateast inhibition obtained through the treatment of "plate platetation" can delay the time of coronary bridge, and has ischemia protection.
    meta-analysis, the researchers compared patients with coronary arterial bridge surgery who had received more effective antiplate plateplate suppression strategies and less effective plateplate suppression strategies, respectively.
    main outcome of the study was the total cause of death in patients after bypass surgery.
    meta-analysis identified four randomized studies and six non-randomized studies of antiplate plate plate therapy.
    In all studies, the overall mortality rate of coronary arterial bridge surgery patients who received less effective plateplate suppression strategies was higher than that of coronary artery bridge surgery patients who received more effective antiplate plate plate suppression strategies (ratio ratio was 1.38; 95% confidence interval was 1.03-1.85; P=0.03).
    results support the role of plate plate rest in reducing mortality in patients with acute coronary artery syndrome who require coronary artery bridge surgery.
    suggests that in patients with acute coronary artery syndrome, more effective antiplate platea therapy strategies should be routinely used in advance, regardless of whether coronary artery bridge is accepted or not.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.